Dynavax Technologies Corporation
2929 Seventh Street
Suite 100
Berkeley,
CA 94710-2753
United States - Map
Phone: 510-848-5100
Fax: 510-848-1327
Web Site: http://www.dynavax.com
| Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. Its lead product candidate includes HEPLISAVTM, a Phase 3 investigational adult hepatitis B vaccine designed to provide protection with fewer doses than current licensed vaccines. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Dino Dina M.D., 62
Chief Exec. Officer, Pres and Exec. Director |
N/A
| N/A | Ms. Deborah A. Smeltzer , 55
Chief Financial Officer and VP of Operations |
N/A
| N/A | Dr. Zbigniew Janowicz Ph.D., 58
Chief Exec. Officer of Dynavax Europe |
$
484.00K | N/A | Dr. Robert L. Coffman Ph.D., 62
Chief Scientific Officer and VP |
N/A
| N/A | Mr. Michael S. Ostrach J.D., 57
Chief Bus. Officer, VP, Sec. and Gen. Counsel |
$
417.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.23% Nasdaq 
0.03 (2.26%) 
Profile
